140 related articles for article (PubMed ID: 9044384)
1. Less induced 1-methyl-4-phenylpyridinium ion neurotoxicity on striatal slices from guinea-pigs fed with a vitamin C-deficient diet.
Revuelta M; Romero-Ramos M; Venero JL; Millan F; Machado A; Cano J
Neuroscience; 1997 Mar; 77(1):167-74. PubMed ID: 9044384
[TBL] [Abstract][Full Text] [Related]
2. In vivo protection of striatal dopaminergic system against 1-methyl-4-phenylpyridinium neurotoxicity by phenobarbital.
Vizuete ML; Merino M; Cano J; Machado A
J Neurosci Res; 1997 Aug; 49(3):301-8. PubMed ID: 9260741
[TBL] [Abstract][Full Text] [Related]
3. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) does not destroy nigrostriatal neurons in the scorbutic guinea pig.
Perry TL; Yong VW; Ito M; Jones K; Wall RA; Foulks JG; Wright JM; Kish SJ
Life Sci; 1985 Apr; 36(13):1233-8. PubMed ID: 2858797
[TBL] [Abstract][Full Text] [Related]
4. Lack of involvement of glutamate-induced excitotoxicity in MPP+ toxicity in striatal dopaminergic terminals: possible involvement of ascorbate.
Matarredona ER; Santiago M; Machado A; Cano J
Br J Pharmacol; 1997 Jul; 121(5):1038-44. PubMed ID: 9222565
[TBL] [Abstract][Full Text] [Related]
5. Chronic effects of single intrastriatal injections of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium studied by microdialysis in freely moving rats.
Espino A; Cutillas B; Tortosa A; Ferrer I; Bartrons R; Ambrosio S
Brain Res; 1995 Oct; 695(2):151-7. PubMed ID: 8556325
[TBL] [Abstract][Full Text] [Related]
6. Correlation between 1-methyl-4-phenylpyridinium ion (MPP+) levels, ascorbic acid oxidation and glutathione levels in the striatal synaptosomes of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated rat.
Desole MS; Esposito G; Fresu L; Migheli R; Enrico P; Miele M; De Natale G; Miele E
Neurosci Lett; 1993 Oct; 161(2):121-3. PubMed ID: 7903798
[TBL] [Abstract][Full Text] [Related]
7. Cerebral monoamine metabolism in guinea-pigs with ascorbic acid deficiency.
Saner A; Weiser H; Hornig D; Da Prada M; Pletscher A
J Pharm Pharmacol; 1975 Dec; 27(12):896-902. PubMed ID: 2659
[TBL] [Abstract][Full Text] [Related]
8. 1-Methyl-4-phenylpyridinium has greater neurotoxic effect after selenium deficiency than after vitamin E deficiency in rat striatum.
Vizuete ML; Steffen V; Machado A; Cano J
Eur J Pharmacol; 1994 Apr; 270(2-3):183-7. PubMed ID: 8039547
[TBL] [Abstract][Full Text] [Related]
9. Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice.
Moy LY; Albers DS; Sonsalla PK
Brain Res; 1998 Apr; 790(1-2):264-9. PubMed ID: 9593931
[TBL] [Abstract][Full Text] [Related]
10. MPP+ toxicity in rat striatal slices: relationship between non-selective effects and free radical production.
Ambrosio S; Espino A; Cutillas B; Bartrons R
Neurochem Res; 1996 Jan; 21(1):73-8. PubMed ID: 8833226
[TBL] [Abstract][Full Text] [Related]
11. The effects of 1-methyl-4-phenylpyridinium ion (MPP+) on the efflux and metabolism of endogenous dopamine in rat striatal slices.
Snape BM; Pileblad E; Ekman A; Magnusson T; Carlsson A; Engel J
J Pharm Pharmacol; 1988 Sep; 40(9):620-6. PubMed ID: 2907028
[TBL] [Abstract][Full Text] [Related]
12. Prolonged alterations in canine striatal dopamine metabolism following subtoxic doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 4'-amino-MPTP are linked to the persistence of pyridinium metabolites.
Johannessen JN; Sobotka TJ; Weise VK; Markey SP
J Neurochem; 1991 Sep; 57(3):981-90. PubMed ID: 1677682
[TBL] [Abstract][Full Text] [Related]
13. Increased extracellular glutamate evoked by 1-methyl-4-phenylpyridinium [MPP(+)] in the rat striatum is not essential for dopaminergic neurotoxicity and is not derived from released glutathione.
Foster SB; Tang H; Miller KE; Dryhurst G
Neurotox Res; 2005; 7(4):251-63. PubMed ID: 16179262
[TBL] [Abstract][Full Text] [Related]
14. L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
Vaglini F; Pardini C; Cavalletti M; Maggio R; Corsini GU
Brain Res; 1996 Nov; 741(1-2):68-74. PubMed ID: 9001706
[TBL] [Abstract][Full Text] [Related]
15. Effects of methylmercury on dopamine release in MN9D neuronal cells.
Shao Y; Chan HM
Toxicol Mech Methods; 2015; 25(8):637-44. PubMed ID: 26056851
[TBL] [Abstract][Full Text] [Related]
16. The non-NMDA glutamate receptor antagonists 6-cyano-7-nitroquinoxaline-2,3-dione and 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline, but not NMDA antagonists, block the intrastriatal neurotoxic effect of MPP+.
Merino M; Vizuete ML; Cano J; Machado A
J Neurochem; 1999 Aug; 73(2):750-7. PubMed ID: 10428073
[TBL] [Abstract][Full Text] [Related]
17. In vivo protection of striatum from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists.
Santiago M; Venero JL; Machado A; Cano J
Brain Res; 1992 Jul; 586(2):203-7. PubMed ID: 1521154
[TBL] [Abstract][Full Text] [Related]
18. 1-methyl-4-phenylpyridinium (MPP+) analogs: in vivo neurotoxicity and inhibition of striatal synaptosomal dopamine uptake.
Johnson EA; Wu EY; Rollema H; Booth RG; Trevor AJ; Castagnoli N
Eur J Pharmacol; 1989 Jul; 166(1):65-74. PubMed ID: 2806366
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
Clarke PB; Reuben M
Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
[TBL] [Abstract][Full Text] [Related]
20. MPP+-induced increases in extracellular potassium ion activity in rat striatal slices suggest that consequences of MPP+ neurotoxicity are spread beyond dopaminergic terminals.
Hollinden GE; Sanchez-Ramos JR; Sick TJ; Rosenthal M
Brain Res; 1988 Dec; 475(2):283-90. PubMed ID: 3265070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
